Litfulo® Capsules Special Investigation
Latest Information Update: 17 Mar 2025
At a glance
- Drugs Ritlecitinib (Primary)
- Indications Alopecia areata
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer
Most Recent Events
- 08 Oct 2024 Status changed from recruiting to active, no longer recruiting.
- 05 Jun 2024 Status changed from not yet recruiting to recruiting.
- 01 Mar 2024 New trial record